Superior Cerebrovascular Outcomes with Tirzepatide versus Semaglutide in Diabetic CABG Patients: A Global Network Study of Propensity-Matched Patients.
Saved in:
| Title: | Superior Cerebrovascular Outcomes with Tirzepatide versus Semaglutide in Diabetic CABG Patients: A Global Network Study of Propensity-Matched Patients. |
|---|---|
| Authors: | Chunduri S; Tulane University School of Medicine, New Orleans, LA, USA., Bidaoui G; Tulane Research Innovation for Arrhythmia Discovery (TRIAD) Center, Tulane University School of Medicine, New Orleans, LA, USA., Hussein MH; Ochsner Clinic Foundation, New Orleans, LA, USA., Patel M; Tulane University School of Medicine, New Orleans, LA, USA., Abdelmaksoud A; Department of Internal Medicine, University of California, Riverside, CA, 92521, USA., Mohamed M; Department of Internal Medicine, University of California, Riverside, CA, 92521, USA., Attia A; Department of Surgery, School of Medicine, Tulane University, New Orleans, LA, 70112, USA., Tatum D; Department of Surgery, School of Medicine, Tulane University, New Orleans, LA, 70112, USA., Borgi J; Department of Surgery, School of Medicine, Tulane University, New Orleans, LA, 70112, USA., Toraih EA; Department of Cardiovascular Perfusion, College of Health Professions, Upstate Medical University, New York, NY, USA. etoraih@tulane.edu.; Genetics Unit, Histology and Cell Biology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt. etoraih@tulane.edu. |
| Source: | Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2026 Jun; Vol. 40 (3), pp. 1001-1011. Date of Electronic Publication: 2025 Sep 12. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7241 (Electronic) Linking ISSN: 09203206 NLM ISO Abbreviation: Cardiovasc Drugs Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
